Articles Referencing WX
Wider-than-Expected Loss at ChemoCentryx - Analyst Blog
5/14/2013, 10:55 am from Zacks.com in Investing, Business, Stocks
ChemoCentryx, Inc. ( CCXI ) reported net
loss of 28 cents per share in the first quarter of 2013, wider than
the Zacks Consensus Estimate of a loss of 27 cents but in line with
the year-ago... Read >>
After-Hours Earnings Report for May 13, 2013 : CPA, IOC, POST, TTWO, WX, HMIN, CCXI, RENN, SVN, GOL, TEAR, FRF
5/13/2013, 2:00 pm from NASDAQ.com News in News Headlines, Earnings
The following companies are expected to report earnings after
hours on 05/13/2013. Visit our Earnings
Calendar for a full list of expected earnings releases. Copa Holdings, S.A. ( CPA ) is... Read >>
Dendreon Narrows 1Q Loss - Analyst Blog
5/10/2013, 10:49 am from Zacks.com in Investing, Business, Stocks
Dendreon Corporation ( DNDN ) reported
first-quarter 2013 loss (including stock-based compensation
expenses) of 37 cents per share, narrower than the Zacks Consensus
Estimate of a loss of... Read >>
Good News for Cubist Pharmaceuticals - Analyst Blog
5/9/2013, 4:24 pm from Zacks.com in Investing, Business, Stocks
Cubist Pharmaceuticals, Inc. ( CBST ) recently
received encouraging news when the US Food and Drug Administration
(FDA) granted the company's antibiotic candidate
ceftolozane/tazobactam... Read >>
Narrower-than-Expected Loss at ArQule - Analyst Blog
5/9/2013, 1:24 pm from Zacks.com in Investing, Business, Stocks
ArQule, Inc. ( ARQL ) recently
reported a loss of 9 cents per share in the first quarter of 2013,
narrower than the Zacks Consensus Estimate of a loss of 11 cents
per share. The company had... Read >>
Wider-than-Expected Loss at Corcept - Analyst Blog
5/7/2013, 12:25 pm from Zacks.com in Investing, Business, Stocks
Corcept Therapeutics Inc. ( CORT ) posted a loss
per share of 11 cents in the first quarter of 2013, wider than the
Zacks Consensus Estimate of a loss of 10 cents. In the year-ago
quarter,... Read >>
Valeant Misses Earnings and Revenue Estimate in 1Q (Revised) - Analyst Blog
5/7/2013, 9:27 am from Zacks.com in Investing, Business, Earnings, Stocks
Valeant Pharmaceuticals' ( VRX ) first quarter
2013 earnings of $1.27 (excluding special items but including
stock-based compensation expense) were short of the Zacks Consensus
Estimate... Read >>
Shire Settles Lawsuit with Actavis - Analyst Blog
5/1/2013, 1:48 pm from Zacks.com in Investing, Business, Stocks
Shire ( SHPG ) recently
announced that the company settled its pending litigation with
Actavis, Inc ( ACT ), formerly known
as Watson Pharmaceuticals. The litigation was primarily... Read >>
ImmunoGen Narrows Loss - Analyst Blog
4/29/2013, 9:46 am from Zacks.com in Investing, Business, Stocks
ImmunoGen Inc. ( IMGN ) reported third
quarter fiscal 2013 (ending Mar 31) loss of 2 cents per share,
narrower than the Zacks Consensus Estimate of a loss of 14 cents
and the year-ago... Read >>
Elan Narrows Y/Y Loss - Analyst Blog
4/25/2013, 1:09 pm from Zacks.com in Investing, Business, Stocks
Elan Corporation ( ELN ) reported a loss
of 12 cents per share from its continuing operations in the first
quarter of 2013, narrower than the year-ago loss of 13 cents per
share. Elan's... Read >>
Earnings Acceleration Can Forecast Big Moves Ahead - Screen of the Week
4/23/2013, 3:15 am from Zacks.com in Investing, Earnings, Investing Ideas, Stocks
In good markets or bad, earnings are one of the most important
things that influence stock prices.
But instead of just looking at only the most recent quarter's
earnings, try looking for... Read >>
Elan Turns Down Royalty's Offer - Analyst Blog
4/22/2013, 1:12 pm from Zacks.com in Investing, Business, Stocks
Elan Corporation 's ( ELN ) Board of
Directors recently rejected Royalty Pharma's offer to acquire all
the shares of Elan for $11.25 or less per share. Elan' Board of Directors believed... Read >>
Elan's Strike Price Stands at $11.25 - Analyst Blog
4/19/2013, 5:13 pm from Zacks.com in Investing, Business, Stocks
Elan Corporation ( ELN ) recently
announced the final results of its modified Dutch auction tender
offer of a maximum aggregate value of $1 billion. The Dutch auction
tender offer, which... Read >>
Pipeline Progress at Alkermes - Analyst Blog
4/18/2013, 6:15 pm from Zacks.com in Investing, Business, Stocks
Alkermes ( ALKS ) recently
announced encouraging top-line data from a phase II study (n=142)
on ALKS 5461. The study evaluated the safety and efficacy of ALKS
5461 across two doses for the... Read >>
Elan Responds to Royalty Pharma Offer - Analyst Blog
4/16/2013, 5:40 pm from Zacks.com in Investing, Business, Stocks
Elan Corporation 's ( ELN ) Board of
Directors recently responded to Echo Pharma Acquisition Limited's
("Royalty Pharma") offer to acquire Elan's shares under Rule 2.5 of
the... Read >>